Boothe Investment Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-64,208
| Closed | -$5.21M | – | 44 |
|
|
2025
Q1 | $5.21M | Buy |
64,208
+366
| +0.6% | +$29.7K | 2.37% | 19 |
|
|
2024
Q4 | $5.75M | Buy |
63,842
+18
| +0% | +$1.62K | 2.5% | 18 |
|
|
2024
Q3 | $6.31M | Sell |
63,824
-861
| -1% | -$85.1K | 2.88% | 15 |
|
|
2024
Q2 | $6.02M | Buy |
+64,685
| New | +$6.02M | 2.79% | 15 |
|
|
2018
Q4 | – | Sell |
-29,111
| Closed | -$2.79M | – | 25 |
|
|
2018
Q3 | $2.79M | Buy |
29,111
+708
| +2% | +$67.9K | 2.6% | 10 |
|
|
2018
Q2 | $2.7M | Buy |
+28,403
| New | +$2.7M | 2.53% | 8 |
|